G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models

Area of Science:

• Neuroscience
• Cell Biology
• Demyelinating Diseases

Background:

• Multiple sclerosis (MS) involves demyelination in both white and gray matter, leading to chronic deficits due to inadequate remyelination.
• The molecular mechanisms governing remyelination and its failures in MS are not fully understood.
• G protein-coupled receptor 17 (GPR17) is implicated in oligodendrocyte development and remyelination, but its role in gray matter and chronic lesions remains unclear.

Purpose of the Study:

• To characterize GPR17 expression during experimental demyelination and remyelination in both white and gray matter.
• To investigate the relevance of GPR17 in gray matter remyelination and chronic white matter lesions.
• To assess the correlation between GPR17 expression and endogenous remyelination capacity.

Main Methods:

• Established experimental demyelination models using acute and chronic cuprizone administration and lysophosphatidylcholine (LPC) injection.
• Analyzed GPR17 expression using immunohistochemistry, in situ hybridization, and real-time PCR.
• Quantified GPR17-positive (GPR17+) cells and assessed their co-localization with oligodendrocyte markers (OLIG2).

Main Results:

• GPR17+ cells, co-expressing OLIG2, were found in control corpus callosum and cortex.
• Acute demyelination induced robust remyelination in white matter, paralleled by increased GPR17 expression, but not in gray matter.
• LPC-induced demyelination also showed increased GPR17+ cells, while chronic demyelination led to GPR17+ cell quiescence.

Conclusions:

• GPR17 expression is induced during acute demyelination and correlates with sufficient endogenous remyelination in white matter.
• GPR17's role in remyelination appears limited in gray matter and chronic lesions.
• Targeting GPR17 may offer a therapeutic strategy to promote endogenous myelin repair in demyelinating diseases like MS.